Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
NEJM Evidence|February 6, 2024
Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell LeukemiaJae H Park, Sean Devlin, Benjamin H Durham, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|February 10, 2022
A Continuing Education Activity Durably Addressed Knowledge Gaps Related to Penicillin Allergies Among Pharmacists and Pharmacy TechniciansElizabeth W Covington, Spencer H Durham, Christopher M Bland, et al.
Cancer Discovery|May 10, 2019
A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1Evangelia Loizou, Ana Banito, Geulah Livshits, et al.
Neuro-Oncology|January 18, 2020
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient seriesAnkush Bhatia, Vaios Hatzoglou, Gary Ulaner, et al.
Blood|March 31, 2026
International Expert Recommendations for the Diagnosis and Treatment of Malignant Histiocytic NeoplasmsGaurav Goyal, Oussama Abla, John K C Chan, et al.
Pharmacotherapy|March 20, 2023
Personalizing prevention: Advances in pharmacotherapy for HIV preventionMarisa Brizzi, Elizabeth M Sherman, Sarah B Green, et al.
Oncogene|September 2, 2018
An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemiaAlok Swaroop, Jon A Oyer, Christine M Will, et al.
Open Forum Infectious Diseases|November 9, 2019
A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2018Elias B Chahine, Spencer H Durham, Krutika N Mediwala, et al.
Blood|August 2, 2018
Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesisElodie Pronier, Robert L Bowman, Jihae Ahn, et al.
Blood|May 18, 2017
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adultsPaul Milne, Venetia Bigley, Chris M Bacon, et al.
Pageof 16